261 related articles for article (PubMed ID: 37248338)
1. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage.
Kumar ST; Nazarov S; Porta S; Maharjan N; Cendrowska U; Kabani M; Finamore F; Xu Y; Lee VM; Lashuel HA
Nat Neurosci; 2023 Jun; 26(6):983-996. PubMed ID: 37248338
[TBL] [Abstract][Full Text] [Related]
2. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
Fang YS; Tsai KJ; Chang YJ; Kao P; Woods R; Kuo PH; Wu CC; Liao JY; Chou SC; Lin V; Jin LW; Yuan HS; Cheng IH; Tu PH; Chen YR
Nat Commun; 2014 Sep; 5():4824. PubMed ID: 25215604
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
4. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
5. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
[TBL] [Abstract][Full Text] [Related]
6. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
Geser F; Lee VM; Trojanowski JQ
Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
[TBL] [Abstract][Full Text] [Related]
7. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
8. TTR (transthyretin) leads the autophagy disaster relief team against TARDBP/TDP-43 proteinopathy.
Chu YP; Ho PC; Tsai KJ
Autophagy; 2023 Aug; 19(8):2403-2405. PubMed ID: 36633448
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
[TBL] [Abstract][Full Text] [Related]
10. Structure of pathological TDP-43 filaments from ALS with FTLD.
Arseni D; Hasegawa M; Murzin AG; Kametani F; Arai M; Yoshida M; Ryskeldi-Falcon B
Nature; 2022 Jan; 601(7891):139-143. PubMed ID: 34880495
[TBL] [Abstract][Full Text] [Related]
11. [Intracellular seeded aggregation of TDP-43].
Nonaka T; Hasegawa M
Rinsho Shinkeigaku; 2012; 52(11):1056-8. PubMed ID: 23196514
[TBL] [Abstract][Full Text] [Related]
12. A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration.
San Gil R; Pascovici D; Venturato J; Brown-Wright H; Mehta P; Madrid San Martin L; Wu J; Luan W; Chui YK; Bademosi AT; Swaminathan S; Naidoo S; Berning BA; Wright AL; Keating SS; Curtis MA; Faull RLM; Lee JD; Ngo ST; Lee A; Morsch M; Chung RS; Scotter E; Lisowski L; Mirzaei M; Walker AK
Nat Commun; 2024 Feb; 15(1):1508. PubMed ID: 38374041
[TBL] [Abstract][Full Text] [Related]
13. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
Liu YC; Chiang PM; Tsai KJ
Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for diseases with TDP-43 pathology.
Steinacker P; Barschke P; Otto M
Mol Cell Neurosci; 2019 Jun; 97():43-59. PubMed ID: 30399416
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils.
Sharma K; Stockert F; Shenoy J; Berbon M; Abdul-Shukkoor MB; Habenstein B; Loquet A; Schmidt M; Fändrich M
Nat Commun; 2024 Jan; 15(1):486. PubMed ID: 38212334
[TBL] [Abstract][Full Text] [Related]
16. An
Cascella R; Banchelli M; Abolghasem Ghadami S; Ami D; Gagliani MC; Bigi A; Staderini T; Tampellini D; Cortese K; Cecchi C; Natalello A; Adibi H; Matteini P; Chiti F
Ann Med; 2023 Dec; 55(1):72-88. PubMed ID: 36495262
[No Abstract] [Full Text] [Related]
17. Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes.
Prater KE; Latimer CS; Jayadev S
Glia; 2022 Feb; 70(2):239-255. PubMed ID: 34558120
[TBL] [Abstract][Full Text] [Related]
18. Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.
Kao PF; Chen YR; Liu XB; DeCarli C; Seeley WW; Jin LW
Ann Neurol; 2015 Aug; 78(2):211-21. PubMed ID: 25921485
[TBL] [Abstract][Full Text] [Related]
19. Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Riku Y; Seilhean D; Duyckaerts C; Boluda S; Iguchi Y; Ishigaki S; Iwasaki Y; Yoshida M; Sobue G; Katsuno M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917673
[TBL] [Abstract][Full Text] [Related]
20. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration.
Bosque PJ; Boyer PJ; Mishra P
PLoS One; 2013; 8(5):e62301. PubMed ID: 23704877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
